4//SEC Filing
Myers W Todd 4
Accession 0001350091-08-000004
CIK 0001125603other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:02 PM ET
Size
8.8 KB
Accession
0001350091-08-000004
Insider Transaction Report
Form 4
Myers W Todd
CFO
Transactions
- Exercise/Conversion
Common Stock
2008-02-05+1,563→ 21,097 total - Sale
Common Stock
2008-02-05$4.40/sh−781$3,436→ 20,316 total - Exercise/Conversion
Restricted Stock Units
2008-02-05−1,563→ 34,375 total→ Common Stock (1,563 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2006.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the restricted stock units vested on December 5, 2006. The remaining restricted stock units vest in equal monthly installments over the subsequent 3 years until December 5, 2009.
Documents
Issuer
SGX PHARMACEUTICALS, INC.
CIK 0001125603
Entity typeother
Related Parties
1- filerCIK 0001350091
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:02 PM ET
- Size
- 8.8 KB